Publications – PromarkerEso

PromarkerEso publications

Learn more about our published research and the science behind the PromarkerEso test

Latest publications

Esophageal cancer diagnostic excels with

Validation of Biomarkers for

A novel serum glycoprotein biomarker

Esophageal cancer diagnostic excels with 94% accuracy in clinical validation study

Peters KE, et al. World first blood test for esophageal cancer shows 94% accuracy in clinical validation study. ISDE, 2024.

Validation of Biomarkers for Oesophageal Cancer

S. Bringans, E. Schoeman, N. Dorta Scott, R.Wang, P.Galettis R. Lipscombe. 29th Annual Proteomics Lorne Symposium in Lorne, Australia, 31 January – 3 February 2024.

A novel serum glycoprotein biomarker panel for screening of esophageal adenocarcinoma and surveillance of Barrett’s esophagus

Oral Presented by R. Lipscombe. R. Lipscombe M.N. Duong, R. Casey, G. Fernadez, S. Bringans, K. Peters, M.M. Hill, P. Tan, L. Chen.19th ISDE World Congress for Esophageal Diseases in Toronto, September 2023.

Development of a Lectin Bead-based Diagnostic Test for Oesophageal Cancer

Presenter: S.D. Bringans, 28th Annual Lorne Proteomics Symposium, February 2023

Semi-Automated Lectin Magnetic Bead Array (LeMBA) for Translational Serum Glycoprotein Biomarker Discovery and Validation

Dutt, M.N. Duong, S. Bringans, R. Richards, R. Lipscombe, M.M. Hill. Book Chapter in Serum/Plasma Proteomics: Methods and Protocols. Springer US, New York, NY, 2023

Establishing a Mass Spectrometry Based Diagnostic Test for Oesophageal Cancer

M.N. Duong, S. Bringans, S. Chen, G. Fernadez, T. Casey, C. Laming, P. Di Prinzio, M.M. Hill, R. Lipscombe. 18th World Congress for Esophageal Diseases in Tokyo, Japan, September 2022

Evaluation of Serum Glycoprotein Biomarker Candidates for Detection of Esophageal Adenocarcinoma and Surveillance of Barrett’s Esophagus

A.K Shah, G. Hartel, I. Brown, C. Winterford, R. Na, K. Le Cao, B.A. Spicer, M.A. Dunstone, W.A. Phillips, R.V. Lord, A.P. Barbour, D.I. Watson, V. Joshi, D.C. Whiteman, M.M. Hill; Mol Cell Proteomics 2018; 17(12): 2324–2334.

More information below

Find out how PromarkerEso can make the difference for you

Access the novel blood test that allows for the diagnosis of esophageal cancer to improve patient outcome